Impact evaluation of a cash-plus programme for children with disabilities in the Xiengkhouang Province in Lao PDR: study protocol for a non-randomised controlled trial.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
13 May 2024
Historique:
medline: 14 5 2024
pubmed: 14 5 2024
entrez: 13 5 2024
Statut: epublish

Résumé

More than 170 countries have implemented disability-targeted social protection programmes, although few have been rigorously evaluated. Consequently, a non-randomised controlled trial is being conducted of a pilot 'cash-plus' programme implemented by UNICEF Laos and the Laos government for children with disabilities in the Xiengkhouang Province in Laos. The intervention combines a regular cash transfer with provision of assistive devices and access for caregivers to a family support programme. The non-randomised controlled trial will involve 350 children with disabilities across 3 districts identified by programme implementers as eligible for the programme (intervention arm). Implementers have also identified approximately 180 children with disabilities in neighbouring districts, who would otherwise meet eligibility criteria but do not live in the project areas (control arm). The trial will assess the impact of the programme on child well-being (primary outcome), as well as household poverty, caregiver quality of life and time use (secondary outcomes). Baseline data are being collected May-October 2023, with endline 24 months later. Analysis will be intention to treat. A complementary process evaluation will explore the implementation, acceptability of the programme, challenges and enablers to its delivery and mechanisms of impact. The study has received ethical approval from the London School of Hygiene and Tropical Medicine and the National Ethics Committee for Health Research in Laos. Informed consent and assent will be taken by trained data collectors. Data will be collected and stored on a secure, encrypted server and its use will follow a detailed data management plan. Findings will be disseminated in academic journals and in short briefs for policy and programmatic actors, and in online and in-person events. ISRCTN80603476.

Identifiants

pubmed: 38740503
pii: bmjopen-2023-081536
doi: 10.1136/bmjopen-2023-081536
doi:

Types de publication

Journal Article Clinical Trial Protocol

Langues

eng

Sous-ensembles de citation

IM

Pagination

e081536

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: LMB has previously worked as a consultant for UNICEF and holds grants in which UNICEF is a collaborator. None of this work is linked to this evaluation and is through UNICEF headquarters rather than UNICEF Laos.

Auteurs

Lena Morgon Banks (LM)

London School of Hygiene and Tropical Medicine, London, UK morgon.banks@lshtm.ac.uk.

Bounhome Soukkhaphone (B)

Lao Tropical & Public Health Institute, Vientiane, Lao People's Democratic Republic.

Nathaniel Scherer (N)

London School of Hygiene and Tropical Medicine, London, UK.

Latsamy Siengsounthone (L)

Lao Tropical & Public Health Institute, Vientiane, Lao People's Democratic Republic.

Mark T Carew (MT)

London School of Hygiene and Tropical Medicine, London, UK.

Tom Shakespeare (T)

London School of Hygiene and Tropical Medicine Faculty of Infectious and Tropical Diseases, London, UK.

Shanquan Chen (S)

London School of Hygiene and Tropical Medicine, London, UK.

Calum Davey (C)

London School of Hygiene and Tropical Medicine, London, UK.

Divya Goyal (D)

Independent Consultant, Bhangaghar, India.

Anja Zinke-Allmang (A)

Department of Global Health & Development, London School of Hygiene and Tropical Medicine, London, UK.

Hannah Kuper (H)

Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.

Ketmany Chanthakoumane (K)

Lao Tropical & Public Health Institute, Vientiane, Lao People's Democratic Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH